Press-release for stocks publishing date 2022 - 02 - 24 in the health technology sector

publishing date : 2022 - 02 - 24 sector : Health technology

save search

Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
Published: 2022-02-24 (Crawled : 16:20) - ir.radiuspharm.com
FNCTF | $11.128 -20.84% 580

Communications

| -10.26% | O: -2.2% H: 0.0% C: -0.14%
RDUS | $17.63 2.14% 2.1% 340K

Health Technology

| 149.42% | O: 3.32% H: 14.41% C: 13.99%
health results

Cyclerion Announces CY6463 Clinical Pipeline and Corporate Updates
Published: 2022-02-24 (Crawled : 16:20) - ir.cyclerion.com
LLY | $750.77 -0.12% 0.0% 2.3M

Health Technology

| 219.87% | O: 3.94% H: 0.0% C: 0.0%
CYCN | $3.37 12.62% 2.4K

Health Technology

| 238.35% | O: 0.4% H: 3.0% C: -3.87%
cy6463 ces

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VXRT | $0.8977 -1.36% -1.38% 1.6M

Health Technology

| -79.22% | O: -9.93% H: 0.0% C: 0.0%
financial results report results

Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SNYNF | $92.9 -2.18% 880

Health Technology

| -9.98% | O: 0.78% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

Health Technology

| -12.55% | O: -4.06% H: 0.0% C: 0.0%
SGMO | $0.5552 2.17% 2.13% 1.7M

Health Technology

| -89.9% | O: -2.04% H: 0.0% C: 0.0%
financial results therapeutics report results

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VIR | $8.55 -4.68% -4.91% 770K

Health Technology

| -67.73% | O: -6.87% H: 0.0% C: 0.0%
GILD | $67.76 -1.3% -1.31% 7.7M

Health Technology

| 10.95% | O: -1.04% H: 0.0% C: 0.0%
ALNY | $147.775 -0.49% -0.49% 490K

Health Technology

| 0.7% | O: -2.95% H: 0.0% C: 0.0%
financial results technology report results biotech iot

Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SILK | $18.05 -0.82% -0.83% 290K

Health Technology

| -37.76% | O: -5.64% H: 0.0% C: 0.0%
financial results report results

Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
AMTI 4 | $0.263 -14.3% -1.14% 0

Health Technology

| -95.78% | O: -4.01% H: 0.0% C: 0.0%
financial results report results molecular

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M

Health Technology

| -8.5% | O: -1.05% H: 0.0% C: 0.0%
EBS F | $1.98 -3.88% 1.01% 1.2M

Health Technology

| -95.15% | O: -1.65% H: 0.0% C: 0.0%
financial results solutions report results merge

MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M

Health Technology

| 289.7% | O: -8.35% H: 0.0% C: 0.0%
MGNX 4 | $16.95 -3.36% -3.48% 820K

Health Technology

| 74.88% | O: -1.99% H: 0.0% C: 0.0%
IMGN | $31.23 0.03% 49M

Health Technology

| 552.19% | O: -2.3% H: 0.0% C: 0.0%
IMAB | $1.81 0.0% 400K

Health Technology

| -92.48% | O: -5.2% H: 0.0% C: 0.0%
financial results results

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LIVN | $53.4 0.77% 0.77% 610K

Health Technology

| -27.67% | O: -0.44% H: 0.0% C: 0.0%
implant ces

Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LLY | $750.77 -0.12% 0.0% 2.3M

Health Technology

| 215.4% | O: -1.4% H: 0.0% C: 0.0%
CRDF | $5.265 -6.15% -6.55% 650K

Health Services

| 109.33% | O: -5.22% H: 0.0% C: 0.0%
report results

Inogen Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
INGN | $7.18 -2.45% -2.51% 310K

Health Technology

| -73.81% | O: -0.93% H: 0.0% C: 0.0%
financial results ces results

Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
AERI | $15.25 0.0%

Health Technology

| 170.04% | O: -1.06% H: 0.0% C: 0.0%
als financial results report results

US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LLY | $750.77 -0.12% 0.0% 2.3M

Health Technology

| 215.4% | O: -1.4% H: 0.0% C: 0.0%
jardiance fda heart

PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
PHAS | $0.0701 -23.97%

Health Technology

| -91.74% | O: 2.61% H: 0.0% C: 0.0%
health als conference

NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0

Health Technology

| -99.65% | O: -3.52% H: 0.0% C: 0.0%
health conference presentation

BRIGGS & STRATTON NAMES MICHELLE KUMBIER AS NEW SVP & PRESIDENT OF ITS TURF & CONSUMER PRODUCTS BUSINESS
Published: 2022-02-24 (Crawled : 00:00) - prnewswire.com
ABT | $108.89 -0.2% 0.04% 4.6M

Health Technology

| -5.03% | O: 3.24% H: 0.0% C: 0.0%

US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021
Published: 2022-02-24 (Crawled : 23:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M

Health Technology